Skip to content

SCHEDULE 13D/AAccepted Jan 21, 8:33 PM ET

Verona Pharma plc SCHEDULE 13D/A

Growth Equity Opportunities Fund IV, LLC

Accepted (ET)

8:33 PM

Jan 21, 2025

Filed

Jan 21, 2025

Documents

3

Size

105.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.